Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group - Erbe, A. K., Wang, W., Carmichael, L., Kim, K., Mendonca, E. A., Song, Y., Hess, D., Reville, P. K., London, W. B., Naranjo, A., Hank, J. A., Diccianni, M. B., Reisfeld, R. A., Gillies, S. D., Matthay, K. K., Cohn, S. L., Hogarty, M. D., Maris, J. M., Park, J. R., Ozkaynak, M. F., Gilman, A. L., Yu, A. L., Sondel, P. M. (The American Association for Cancer Research (AACR), 2018)
6128586
Keywords: WW-YZ